Gonococcal antimicrobial susceptibility surveillance in Europe – 2010
In 2010, 21 EU/EEA Member States participated in the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), testing a total of 1766 isolates.
Euro-GASP 2010 identified a significant increase in the proportion of tested isolates that show decreased susceptibility to cefixime, from 4% in 2009 to 9% in 2010, using a cut-off of &gt;0.125 mg/L. Rates of ciprofloxacin and azithromycin resistance remain high (53% and 7%, respectively).
The rapid increase and spread of decreased susceptibility to cefixime is extremely concerning as cefixime is a recommended therapy for gonorrhoea across Europe, as is ceftriaxone.
Poliomyelitis - Annual Epidemiological Report for 2018
14 Sep 2021 - The WHO European Region was declared polio-free in 2002. Neither wild-type nor vaccine-type viruses were notified in the WHO European Region in 2018, but the risk of importation and subsequent transmission remain high in some countries.
Tuberculosis - Annual Epidemiological Report for 2019
13 Sep 2021 - In 2019, 29 countries in the European Union/European Economic Area (EU/EEA) reported a total of 49 752 tuberculosis (TB) cases (9.6 per 100 000 population).